首页> 美国卫生研究院文献>Clinical Orthopaedics and Related Research >Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis
【2h】

Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis

机译:病理骨折相关骨肉瘤的临床和分子分析:microRNA型材不同与预后相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNAs are small, noncoding RNAs that regulate the expression of posttranslational genes. The presence of some specific microRNAs has been associated with increased risk of both local recurrence and metastasis and worse survival in patients with osteosarcoma. Pathologic fractures in osteosarcoma are considered to be more the manifestation of a neoplasm with a more aggressive biological behavior than the cause itself of worse prognosis. However, this has not been proved at the biological or molecular level. Currently, there has not been a microRNA profiling study of patients who have osteosarcoma with and without pathologic fractures that has described differences in terms of microRNA profiling between these two groups and their correlation with biologic behavior.
机译:MicroRNA是小的,非编码RNA,用于调节后期后期基因的表达。一些特异性微小RNA的存在与局部复发和转移的风险增加有关,并且骨肉瘤患者的存活率较差。骨肉瘤中的病理骨折被认为是肿瘤的表现,具有更具侵略性生物行为的肿瘤,其原因本身是更糟糕的预后。然而,这尚未得到生物学或分子水平。目前,患有患者的微小RNA分析研究,其中患有骨肉瘤的患者,没有病理骨折,所述病理骨折已经描述了这两组之间微小RNA分析的差异及其与生物行为的相关性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号